MVM
SNTI icon

Menlo Ventures Management’s Senti Biosciences Holdings SNTI Stock Holding History

Menlo Ventures Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29K Buy
+35,737
New +$34.6K 0.01% 3

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Menlo Ventures Management's SNTI Position: Q1 2026 in Review

Menlo Ventures Management opened a new position in Senti Biosciences Holdings (SNTI) in Q1 2026: 35,737 shares worth $29K. The stake represents 0.01% of the portfolio and ranks #3 among its holdings.

16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • Menlo Ventures Management held 35,737 shares of Senti Biosciences Holdings worth $29K as of Q1 2026.
  • Senti Biosciences Holdings was a new Menlo Ventures Management position in Q1 2026.
  • Senti Biosciences Holdings made up 0.01% of Menlo Ventures Management's portfolio in Q1 2026, its #3 holding.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on Menlo Ventures Management's 13F filing for Q1 2026, filed 15 May 2026.